(Q46457587)

English

Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

author name string

Paoluzi OA

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Iacopini F

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Pica R

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Crispino P

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Marcheggiano A

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Consolazio A

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Rivera M

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Paoluzi P

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

21

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

1111-1119

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

Review article: maintenance of remission in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Maintenance therapy for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

How effective are the usual treatments for ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Mesalazine-associated interstitial nephritis: twice in the same patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02458.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02458.X

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15854173

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46457587&oldid=2112499526"